The Enterprise Value as of December 2025 (TTM) for Rapport Therapeutics, Inc. Common Stock (RAPP) is 807.99M

According to Rapport Therapeutics, Inc. Common Stock’s latest financial reports and current stock price. The company's current Enterprise Value is 807.99M. This represents a change of -84.05% compared to the average of 5.07B of the last 4 quarters.

Rapport Therapeutics, Inc. Common Stock (RAPP) Historical Enterprise Value (quarterly & annually)

How has RAPP Enterprise Value performed in the past?

The mean historical Enterprise Value of Rapport Therapeutics, Inc. Common Stock over the last ten years is 3.83B. The current 807.99M Enterprise Value has changed 2.01% with respect to the historical average. Over the past ten years (40 quarters), RAPP's Enterprise Value was at its highest in in the September 2025 quarter at 11.03B. The Enterprise Value was at its lowest in in the March 2023 quarter at 0.

Rapport Therapeutics, Inc. Common Stock (RAPP) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Rapport Therapeutics, Inc. Common Stock Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Rapport Therapeutics, Inc. Common Stock (RAPP) Average Enterprise Value

How has RAPP Enterprise Value performed in the past?

The current Enterprise Value of Rapport Therapeutics, Inc. Common Stock (RAPP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Rapport Therapeutics, Inc. Common Stock (RAPP) Enterprise Value vs. Peers

How is RAPP’s Enterprise Value compared to its peers?

Rapport Therapeutics, Inc. Common Stock’s Enterprise Value is less than Nurix Therapeutics, Inc. (1.36B), less than Kodiak Sciences Inc. (1.30B), less than Phathom Pharmaceuticals, Inc. (913.24M), less than Xencor, Inc. (1.46B), greater than BridgeBio Oncology Therapeutics Inc. (517.22M), less than AnaptysBio, Inc. (1.10B), less than Mind Medicine (MindMed) Inc. (919.17M), less than UroGen Pharma Ltd. (1.17B), greater than Oculis Holding AG (765.12M), less than Septerna, Inc. (875.41M),

Build a custom stock screener for Rapport Therapeutics, Inc. Common Stock (RAPP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Rapport Therapeutics, Inc. Common Stock using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Rapport Therapeutics, Inc. Common Stock (RAPP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Rapport Therapeutics, Inc. Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.